We hereby inform that the Board of Directors of the Company at its meeting held today i.e. on Friday, May 29, 2026, inter alia, considered and approved the following matters: 1. Audited ....
MKPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
M. K. Proteins Limited reported audited standalone financial results for Q4 and year ended March 31, 2026. Revenue from operations grew significantly to Rs 38,287.52 Lakhs from Rs 26,770.60 Lakhs in the previous year, representing approximately 43% year-on-year growth. However, profit after tax declined to Rs 682.90 Lakhs from Rs 839.74 Lakhs (down about 19%), while profit before tax fell to Rs 938.86 Lakhs from Rs 1,145.10 Lakhs (down about 18%). Basic EPS stood at Rs 0.18 versus Rs 0.22 in the prior year. The company reduced its outstanding borrowings from Rs 37.75 Crores to Rs 36.19 Crores during the year. Statutory auditors Subhash Sajal and Associates issued an unmodified opinion, and cost auditors K. K. Sinha & Associates and internal auditors M/s. Jayant Bansal & Co. were re-appointed for FY 2026-27.
Revenue growth was strong at 43%, but profitability declined by about 19% indicating margin compression due to higher input costs and finance costs. The stock is likely to see mixed reaction with positive revenue momentum offset by declining bottom-line performance.